Spectral Medical Inc.
EDT.TO
TSX
| 09/30/2024 | 06/30/2024 | ||||
|---|---|---|---|---|---|
| Revenue | 6.94% | -30.53% | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | 6.94% | -30.53% | |||
| Cost of Revenue | -15.44% | 37.07% | |||
| Gross Profit | 111.37% | -78.96% | |||
| SG&A Expenses | -26.28% | 63.59% | |||
| Depreciation & Amortization | -88.31% | 312.76% | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | -29.02% | 73.31% | |||
| Operating Income | 32.82% | -105.83% | |||
| Income Before Tax | -127.80% | -4.34% | |||
| Income Tax Expenses | -- | -- | |||
| Earnings from Continuing Operations | -127.80% | -4.34% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | -- | |||
| Net Income | -127.80% | -4.26% | |||
| EBIT | 32.82% | -105.83% | |||
| EBITDA | 33.05% | -107.27% | |||
| EPS Basic | -126.09% | -4.55% | |||
| Normalized Basic EPS | -126.39% | -4.35% | |||
| EPS Diluted | -126.09% | -4.55% | |||
| Normalized Diluted EPS | -126.39% | -4.35% | |||
| Average Basic Shares Outstanding | 0.59% | 0.21% | |||
| Average Diluted Shares Outstanding | 0.59% | 0.21% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||
